OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN Drug Patent Profile
✉ Email this page to a colleague
When do Oxycodone Hydrochloride And Acetaminophen patents expire, and what generic alternatives are available?
Oxycodone Hydrochloride And Acetaminophen is a drug marketed by Vintage Pharms and is included in one NDA.
The generic ingredient in OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN is acetaminophen; oxycodone hydrochloride. There are sixty-six drug master file entries for this compound. Thirty-six suppliers are listed for this compound. Additional details are available on the acetaminophen; oxycodone hydrochloride profile page.
Summary for OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Clinical Trials: | 140 |
| Formulation / Manufacturing: | see details |
| DailyMed Link: | OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN at DailyMed |
Recent Clinical Trials for OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Ciusss de L'Est de l'Île de Montréal | N/A |
| Lee A. Kral | Phase 4 |
| University of Tennessee | Phase 4 |
See all OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN clinical trials
Anatomical Therapeutic Chemical (ATC) Classes for OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN
US Patents and Regulatory Information for OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Vintage Pharms | OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN | acetaminophen; oxycodone hydrochloride | SOLUTION;ORAL | 203573-001 | Dec 18, 2014 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
